Welcome to the Humans of Nutrition Podcast brought to you by Registered Nutritionists Anna Wheeler and Prof Danielle McCarthy.
“There's data at the moment that shows a million pens* are being shipped monthly through private onlinepharmacies in the UK” (*weight loss injectables)
Are you up to speed with the rate of change in this area?
Anna and Danielle chat to Lucy Jones, dietitian andChief Clinical Officer at Oviva, a company transforming the way people access chronic disease care throughtechnology. The conversation has a particular focus on GLP-1RA’s. If you’re not familiar with that term, you almost definitely will have heard of Mounjaro or Ozempic (other brands are available!)
With humour, passion, enthusiasm and eloquence, Lucy guides us through everything you need to know about GLP-1 medications, from the science, current clinical trials and new medications in the pipeline, interspersed with the human experience of using weight loss medication, all wrapped up in the value of embracing digital technology and AI, while keeping nutrition, lifestyle and behaviour change at the heart!
Listen in to find out:How do GLP-1RA’s work? What happens when people stop taking medication? How can people be supported in the weight maintenance phase? How do we make medication and nutrition supportmore accessible? What other medications are in the pipeline? What impact might be felt within the food industry?- What would Lucy do if she was president for the day?!!
Lucy describes her work in the current landscape as “quite aride to be on”. With references to clinical trials, an impassioned plea for nutrition professionals to “skill up”in the digital and AI spaces to ensure scalable solutions, and a look to the future - listen in to join this ride!
Resources referenced:
University of Oxford - Weight regain following thecessation of GLP-1 RAs for weight management: a systematic review andmeta-analysis. West et al 2025: www.phc.ox.ac.uk/files/research/eco-2025-poster_samwest.pdf/@@download
Tony Blair Institute for Global Change: Anti-ObesityMedications: Faster, Broader Access Can Drive Health and Wealth in the UK
Step Up Trail: https://clinicaltrials.gov/study/NCT05646706;https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=915087
Surmount 5 trial: Tirzepatide asCompared with Semaglutide for the Treatment of Obesity | New England Journal ofMedicine
- - - - - - - - - - - - - - - -
We are cognisant that there are other weight loss supports available, and that strides must also be made be made in the area of prevention.
- - - - - - - - - - - - - - - -
As nutrition professionals working in multiple contexts, we want to use our diverse experience to help organisations achieve their nutrition and health goals by providing them with the expertise they need, when they need it.
- - - - - - - - - - - - - - - -
Is there a nutrition topic you’d like to hear discussed? Or a ‘Human of Nutrition’ you think would make a great guest? Email us at info@nutritiontalent.com.
- - - - - - - - - - - - - - - -
Help spread the word! Please share this episode with 1 person who you think might enjoy it.
- - - - - - - - - - - - - - - -
Get in touch to find out more about our company, Nutrition Talent and how we could work together.
Email: info@nutritiontalent.com
LinkedIn: @NutritionTalent
Instagram: @Nutrition_talent
Follow Anna
LinkedIn: @Anna Wheeler
Follow Danielle
LinkedIn: @DrDanielleMcCarthy